All Posts: translational research

• Experimental Therapy Shows Promise in Pancreatic Cancer Clinical Trial

  Clinicians at Georgetown University’s Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first six patients with metastatic pancreatic cancer enrolled in a phase 2 clinical trial of the experimental drug BXCL701 in combination with the immunotherapy drug pembrolizumab (Keytruda). Immunotherapy drugs alone have not shown to be responsive to pancreatic cancer.

  Category: News Release Tags: clinical trials, pancreatic cancer, translational research

• Could a Georgetown Lab Finding Lead to New Treatment in Pancreatic Cancer?

  For the first time, new research by Georgetown scientists shows potential to make immunotherapy effective in pancreatic cancer by combining it with a drug that makes cancer cells more responsive to immunotherapy. The research is now in a phase 2 clinical trial being tested in human patients.

  Category: Lombardi Stories Tags: cancer, cancer research, clinical trials, immunotherapy, pancreatic cancer, translational research